DRKS00030723
Not yet recruiting
Not Applicable
Prospective observational cohort study on the correlation of microbiome diversity and oncological outcome in immune checkpoint inhibitor therapy - MicrobiomCheckpoint01
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C00-C97
- Sponsor
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Voluntarily agree to participate in this study, fully understand the study and sign the informed consent form (ICF).
- •\=18 years old
- •Are you planning treatment with a checkpoint inhibitor (anti\-PD\-1, anti\-PD\-L1, or anti\-CTLA\-4\) alone or in combination with another checkpoint inhibitor or treatment agent or modality (eg, B. Targeted therapy, chemotherapy, surgery, radiation, etc.) in accordance with the use of the active substance approved by the EMA/BfArM
- •Life expectancy \= 6 months
- •Willingness to provide stool samples for research purposes
Exclusion Criteria
- •Voluntarily agree to participate in this study, fully understand the study and sign the informed consent form (ICF).
- •\=18 years old
- •Are you planning treatment with a checkpoint inhibitor (anti\-PD\-1, anti\-PD\-L1, or anti\-CTLA\-4\) alone or in combination with another checkpoint inhibitor or treatment agent or modality (eg, B. Targeted therapy, chemotherapy, surgery, radiation, etc.) in accordance with the use of the active substance approved by the EMA/BfArM
- •Life expectancy \= 6 months
- •Willingness to provide stool samples for research purposes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
This is a type of cancer found in elderly patientsCTRI/2022/09/045751Investigator initiated trial
Completed
Not Applicable
Venous thromboembolism in care homesISRCTN80889792niversity of Birmingham (UK)1,000
Not yet recruiting
Not Applicable
Rate of multidrug resistance to antimicrobial drugs in paediatric neurointensive care patientsHealth Condition 1: Z163- Resistance to other antimicrobialdrugsCTRI/2019/10/021721All India institute of medical sciences
Not yet recruiting
Not Applicable
Investigating the Causes of Revision Lumbar Spine Surgery: A 6-Month Follow-up Prospective Observational Study at a Tertiary Care Spine InstituteHealth Condition 1: M430- SpondylolysisCTRI/2024/01/061208Stavya Spine Hospital and Research Institute
Not yet recruiting
Not Applicable
PROBEL; Prognostics in the Treatment Evaluation of the National System for Veterans' CarePosttraumatische Stressstoornis, Posttraumatic Stress DisorderNL-OMON29049Stichting Centrum '45 partner in ARQ National Psychotrauma Center, Diemen/Oegstgeest, the Netherlands260